MUCOSOLVAN 30mg Price

Overview

Welcome to Dwaey, specifically on MUCOSOLVAN 30mg Tablets page.
This medicine contains an important and useful components, as it consists of Ambroxol HCl.
MUCOSOLVAN 30mg is available in the market in concentration 30mg/Tablet and in the form of Tablets.

BOEHRINGER INGELHEIM INTERNATIONAL GmbH is the producer of MUCOSOLVAN 30mg and it is imported from GERMANY, The most popular alternatives of MUCOSOLVAN 30mg are listed downward .

Mode Of Action

Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.

Indication

• Mucolytic
• Productive cough
• Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis
• laryngitis
• Pharyngitis
• sinusitis and rhinitis associated with viscid mucus
• Asthmatic bronchitis
• bronchial asthma with thick expectoration
• Bronchiectasis
• Chronic pneumonia.

Precaution

Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.

Side Effects

• Tablet: Gastrointestinal Disorders: Dyspepsia
• nausea
• vomiting
• diarrhoea and abdominal pain. Immune System
• Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock
• angioedema
• rash
• urticaria
• pruritus and other hypersensitivity. Syrup: Gastrointestinal
• Respiratory
• Mediastinal and Thoracic Disorders: Dyspepsia
• nausea
• vomiting
• diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat. Nervous System Disorders: Dysgeusia (eg
• changed taste). Immune System
• Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock
• angioedema
• rash
• urticaria
• pruritus and other hypersensitivity.

Contra indication

Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.

Pregnancy and lactation